Clinical connectivity map for drug repurposing: using laboratory results to bridge drugs and diseases
Abstract Background Drug repurposing, the process of identifying additional therapeutic uses for existing drugs, has attracted increasing attention from both the pharmaceutical industry and the research community. Many existing computational drug repurposing methods rely on preclinical data (e.g., c...
Main Authors: | Qianlong Wen, Ruoqi Liu, Ping Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-09-01
|
Series: | BMC Medical Informatics and Decision Making |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12911-021-01617-4 |
Similar Items
-
Systematic polypharmacology and drug repurposing via an integrated L1000-based Connectivity Map database mining
by: Tsang-Pai Liu, et al.
Published: (2018-01-01) -
L1000 connectivity map interrogation identifies candidate drugs for repurposing as SARS-CoV-2 antiviral therapies
by: Wezi Sendama
Published: (2020-01-01) -
Connecting Chemical and Omics Domains for Drug Discovery and Repurposing
by: Reigle, James K., M.S.
Published: (2021) -
Identification of 37 Heterogeneous Drug Candidates for Treatment of COVID-19 via a Rational Transcriptomics-Based Drug Repurposing Approach
by: Andrea Gelemanović, et al.
Published: (2021-01-01) -
VARIANTS AND PERSPECTIVES OF DRUG REPURPOSING FOR CANCER TREATMENT
by: A. V. Savinkova, et al.
Published: (2018-07-01)